-+ 0.00%
-+ 0.00%
-+ 0.00%

EMERGENT BIOSOLUTIONS AWARDED CONTRACT MODIFICATION VALUED AT APPROXIMATELY $24 MILLION FOR CYFENDUS® (ANTHRAX VACCINE ADSORBED, ADJUVANTED)

Reuters·09/01/2026 11:55:01

Please log in to view news